Browsing Centre for Genomics and Child Health by Author "Badodi, S"
Now showing items 1-11 of 11
-
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
Badodi, S; Pomella, N; Lim, YM; Brandner, S; Morrison, G; Pollard, SM; Zhang, X; Zabet, NR; Marino, S (2022) -
Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
Badodi, S; Dubuc, A; Zhang, X; Rosser, G; Jaeger, MDC; Kameda-Smith, MM; Morrissy, AS; Guilhamon, P; Suetterlin, P; Li, X-N (2017-12-05) -
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2C alpha 1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy
Baruffaldi, F; Montarras, D; Basile, V; De Feo, L; Badodi, S; Ganassi, M; Battini, R; Nicoletti, C; Imbriano, C; Musaro, A (2017-03) -
Epigenetic mechanisms in paediatric brain tumours: regulators lose control
Badodi, S; Marino, S (2022) -
INOSITOL TREATMENT INHIBITS MEDULLOBLASTOMA THROUGH SUPPRESSION OF EPIGENETIC-DRIVEN METABOLIC ADAPTATION
Badodi, S; Pomella, N; Zhang, X; Morrison, G; Pollard, SM; Bennett, CD; Clifford, SC; Peet, A; Marino, S (2021-06)Abstract EMBR-10 -
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation.
Marino, S; Badodi, S (Nature Research (part of Springer Nature), 2021-04-12)Deregulation of chromatin modifiers plays an essential role in the pathogenesis of medulloblastoma, the most common paediatric malignant brain tumour. Here, we identify a BMI1-dependent sensitivity to deregulation of ... -
MDB-16. TARGETING EPIGENETIC DYSREGULATION IN PAEDIATRIC BRAIN TUMOURS
Badodi, S; Marino, S (Oxford University Press (OUP), 2023-06-12) -
MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
Badodi, S; Pomella, N; Zhang, X; Zabet, NR; Basson, MA; Marino, S (Oxford University Press (OUP), 2022-06-03) -
NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma.
Frisira, E; Rashid, F; Varma, SN; Badodi, S; Benjamin-Ombo, VA; Michod, D; Niklison-Chirou, MV (Nature Research (part of Springer Nature), 2019-10-16)Medulloblastoma (MB) is the most common malignant solid paediatric brain tumour. The standard treatment for MB is surgical resection of the tumour, radiation and chemotherapy. This therapy is associated with high morbidity ... -
P03.08.A HIGH-DIMENSIONAL CHARACTERISATION OF THE CELLULAR AND MOLECULAR CHANGES IN THE HUMAN BRAIN AFTER RADIOTHERAPY
Millner, TO; Panday, P; Pomella, N; Badodi, S; Marino, S (Oxford University Press (OUP), 2023-09-08) -
TARGETING EPIGENETIC DYSREGULATION IN MEDULLOBLASTOMA WITH POOR PROGNOSIS
Badodi, S; Pomella, N; Zhang, X; Zabet, NR; Basson, MA; Marino, S (2022)